Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Has Already Signed Material Transfer Agreement With Global Strategic Medical Company

SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Has Already Signed Material Transfer Agreement With Global Strategic Medical Company

posted on Oct 04, 2022 12:51PM

Share
New Message
Please login to post a reply